Mark V. Pinti

1.4k total citations · 1 hit paper
26 papers, 986 citations indexed

About

Mark V. Pinti is a scholar working on Molecular Biology, Cancer Research and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Mark V. Pinti has authored 26 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Mark V. Pinti's work include MicroRNA in disease regulation (6 papers), RNA modifications and cancer (6 papers) and Mitochondrial Function and Pathology (5 papers). Mark V. Pinti is often cited by papers focused on MicroRNA in disease regulation (6 papers), RNA modifications and cancer (6 papers) and Mitochondrial Function and Pathology (5 papers). Mark V. Pinti collaborates with scholars based in United States and Japan. Mark V. Pinti's co-authors include John M. Hollander, Quincy A. Hathaway, Andrya J. Durr, Amina Kunovac, Garrett K. Fink, Danielle L. Shepherd, C.E. Nichols, Timothy R. Nurkiewicz, Pushkar Saralkar and Andrew D. Taylor and has published in prestigious journals such as PLoS ONE, Free Radical Biology and Medicine and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

Mark V. Pinti

25 papers receiving 977 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis

2019 297 citations Mark V. Pinti, Garrett K. Fink et al. American Journal of Physiology-Endocrinology and Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark V. Pinti United States	17	499	190	165	97	85	26	986
Srinivas D Sithu United States	19	368 0.7×	182 1.0×	211 1.3×	174 1.8×	111 1.3×	24	1.2k
Ying Yu China	16	439 0.9×	144 0.8×	83 0.5×	107 1.1×	86 1.0×	63	984
Richard C. Jin United States	12	425 0.9×	195 1.0×	123 0.7×	58 0.6×	62 0.7×	14	1.1k
Danielle L. Shepherd United States	18	590 1.2×	214 1.1×	176 1.1×	129 1.3×	63 0.7×	23	962
Sungmi Park South Korea	17	397 0.8×	118 0.6×	139 0.8×	48 0.5×	79 0.9×	38	1.0k
Beibei Wang China	20	515 1.0×	144 0.8×	98 0.6×	66 0.7×	76 0.9×	91	1.2k
Yaowen Fu China	22	534 1.1×	119 0.6×	139 0.8×	111 1.1×	173 2.0×	59	1.4k
Chae‐Myeong Ha United States	16	688 1.4×	138 0.7×	247 1.5×	59 0.6×	195 2.3×	20	1.3k
Aiming Xu China	22	582 1.2×	359 1.9×	241 1.5×	84 0.9×	57 0.7×	51	1.5k

Countries citing papers authored by Mark V. Pinti

Since Specialization

Citations

This map shows the geographic impact of Mark V. Pinti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark V. Pinti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark V. Pinti more than expected).

Fields of papers citing papers by Mark V. Pinti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark V. Pinti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark V. Pinti. The network helps show where Mark V. Pinti may publish in the future.

Co-authorship network of co-authors of Mark V. Pinti

This figure shows the co-authorship network connecting the top 25 collaborators of Mark V. Pinti. A scholar is included among the top collaborators of Mark V. Pinti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark V. Pinti. Mark V. Pinti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taylor, Andrew D., Quincy A. Hathaway, Andrya J. Durr, et al.. (2024). Diabetes mellitus disrupts lncRNA Malat1 regulation of cardiac mitochondrial genome-encoded protein expression. American Journal of Physiology-Heart and Circulatory Physiology. 327(6). H1503–H1518. 5 indexed citations

Taylor, Andrew D., Quincy A. Hathaway, Amina Kunovac, et al.. (2024). Mitochondrial sequencing identifies long noncoding RNA features that promote binding to PNPase. American Journal of Physiology-Cell Physiology. 327(2). C221–C236. 3 indexed citations

Pinti, Mark V., et al.. (2023). Exercise intensity and sex alter neurometabolic, transcriptional, and functional recovery following traumatic brain injury. Experimental Neurology. 368. 114483–114483. 6 indexed citations

Durr, Andrya J., Quincy A. Hathaway, Amina Kunovac, et al.. (2023). Machine learning for spatial stratification of progressive cardiovascular dysfunction in a murine model of type 2 diabetes mellitus. PLoS ONE. 18(5). e0285512–e0285512.

Gao, Ling, Ikuo Yamamiya, Mark V. Pinti, et al.. (2023). A phase I, open‐label, single‐dose study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of futibatinib. Clinical and Translational Science. 16(9). 1713–1724. 3 indexed citations

Durr, Andrya J., Quincy A. Hathaway, Amina Kunovac, et al.. (2022). Manipulation of the miR-378a/mt-ATP6 regulatory axis rescues ATP synthase in the diabetic heart and offers a novel role for lncRNA Kcnq1ot1. American Journal of Physiology-Cell Physiology. 322(3). C482–C495. 23 indexed citations

Saralkar, Pushkar, Alexander Mdzinarishvili, Tasneem Arsiwala, et al.. (2021). The Mitochondrial mitoNEET Ligand NL-1 Is Protective in a Murine Model of Transient Cerebral Ischemic Stroke. Pharmaceutical Research. 38(5). 803–817. 10 indexed citations

Geldenhuys, Werner J., Debbie Piktel, Stephanie L. Rellick, et al.. (2021). Loss of the redox mitochondrial protein mitoNEET leads to mitochondrial dysfunction in B-cell acute lymphoblastic leukemia. Free Radical Biology and Medicine. 175. 226–235. 12 indexed citations

Weil, Zachary M., Kate Karelina, Mark V. Pinti, et al.. (2021). Mild traumatic brain injury increases vulnerability to cerebral ischemia in mice. Experimental Neurology. 342. 113765–113765. 16 indexed citations

10.

Hathaway, Quincy A., William T. Goldsmith, Amina Kunovac, et al.. (2021). Transcriptomics of single dose and repeated carbon black and ozone inhalation co-exposure highlight progressive pulmonary mitochondrial dysfunction. Particle and Fibre Toxicology. 18(1). 44–44. 17 indexed citations

11.

Pinti, Mark V., et al.. (2021). Mitochondrial membranes modify mutant huntingtin aggregation. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1863(10). 183663–183663. 16 indexed citations

12.

Shah, Neal, Zhongwei Liu, Afroz S. Mohammad, et al.. (2020). Drug resistance occurred in a newly characterized preclinical model of lung cancer brain metastasis. BMC Cancer. 20(1). 292–292. 15 indexed citations

13.

Hathaway, Quincy A., Mark V. Pinti, Amina Kunovac, et al.. (2019). Machine-learning to stratify diabetic patients using novel cardiac biomarkers and integrative genomics. Cardiovascular Diabetology. 18(1). 78–78. 68 indexed citations

14.

Pinti, Mark V., Garrett K. Fink, Quincy A. Hathaway, et al.. (2019). Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis. American Journal of Physiology-Endocrinology and Metabolism. 316(2). E268–E285. 297 indexed citations breakdown →

15.

Kunovac, Amina, Quincy A. Hathaway, Mark V. Pinti, et al.. (2019). ROS promote epigenetic remodeling and cardiac dysfunction in offspring following maternal engineered nanomaterial (ENM) exposure. Particle and Fibre Toxicology. 16(1). 24–24. 40 indexed citations

16.

Geldenhuys, Werner J., Timothy E. Long, Pushkar Saralkar, et al.. (2019). Crystal structure of the mitochondrial protein mitoNEET bound to a benze-sulfonide ligand. Communications Chemistry. 2(1). 21 indexed citations

17.

Shepherd, Danielle L., Quincy A. Hathaway, C.E. Nichols, et al.. (2018). Mitochondrial proteome disruption in the diabetic heart through targeted epigenetic regulation at the mitochondrial heat shock protein 70 (mtHsp70) nuclear locus. Journal of Molecular and Cellular Cardiology. 119. 104–115. 19 indexed citations

18.

Shah, Neal, Afroz S. Mohammad, Pushkar Saralkar, et al.. (2018). Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases. Pharmacological Research. 132. 47–68. 105 indexed citations

19.

Stapleton, Phoebe A., Quincy A. Hathaway, C.E. Nichols, et al.. (2018). Maternal engineered nanomaterial inhalation during gestation alters the fetal transcriptome. Particle and Fibre Toxicology. 15(1). 3–3. 36 indexed citations

20.

Shepherd, Danielle L., Quincy A. Hathaway, Mark V. Pinti, et al.. (2017). Exploring the mitochondrial microRNA import pathway through Polynucleotide Phosphorylase (PNPase). Journal of Molecular and Cellular Cardiology. 110. 15–25. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact